[Treatment of lymphatic system diseases with actinomycin C].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003609:Dactinomycin / Q000031:analogs & derivatives; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008208:Lymphatic System
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; C030013:cactinomycin; D003609:Dactinomycin
ANTIBIOTICS/therapeutic use; CYTOTOXIC DRUGS/therapeutic use; HODGKIN'S DISEASE/therapy; LEUKEMIA, LYMPHATIC/therapy
Die Behandlung von Erkrankungen des lymphatischen Systems mit Actinomycin C.